These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15954410)

  • 21. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992.
    Blaese RM; Culver KW; Chang L; Anderson WF; Mullen C; Nienhuis A; Carter C; Dunbar C; Leitman S; Berger M
    Hum Gene Ther; 1993 Aug; 4(4):521-7. PubMed ID: 7691188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy fulfilling its promise.
    Kohn DB; Candotti F
    N Engl J Med; 2009 Jan; 360(5):518-21. PubMed ID: 19179320
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
    Taupin P
    IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID.
    Bordignon C; Mavilio F; Ferrari G; Servida P; Ugazio AG; Notarangelo LD; Gilboa E; Rossini S; O'Reilly RJ; Smith CA
    Hum Gene Ther; 1993 Aug; 4(4):513-20. PubMed ID: 8399494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.
    Van Eyck L; Hershfield MS; Pombal D; Kelly SJ; Ganson NJ; Moens L; Frans G; Schaballie H; De Hertogh G; Dooley J; Bossuyt X; Wouters C; Liston A; Meyts I
    J Allergy Clin Immunol; 2015 Jan; 135(1):283-7.e5. PubMed ID: 25457153
    [No Abstract]   [Full Text] [Related]  

  • 26. PEG-ADA: an alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency.
    Hershfield MS
    Hum Mutat; 1995; 5(2):107-12. PubMed ID: 7749407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine Deaminase Deficient SCID with Myocardial Hypertrophy.
    Flinn AM; Flood T; Prendiville T; Gennery AR; Leahy TR
    J Clin Immunol; 2021 Jul; 41(5):1128-1130. PubMed ID: 33709203
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic manipulation of hematopoietic stem cells in adenosine deaminase deficiency.
    Williams DA; Moritz T
    Adv Exp Med Biol; 1994; 370():395-400. PubMed ID: 7660937
    [No Abstract]   [Full Text] [Related]  

  • 29. [Adenosine deaminase in severe combined immunodeficiency syndrome].
    Pérez-Aguilar MC; Goncalves L; Bonfante-Cabarcas R
    Invest Clin; 2012 Sep; 53(3):315-24. PubMed ID: 23248974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe combined immunodeficiency disease, adenosine deaminase deficiency and gene therapy.
    Parkman R; Gelfand EW
    Curr Opin Immunol; 1991 Aug; 3(4):547-51. PubMed ID: 1755981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The multiple causes of human SCID.
    Buckley RH
    J Clin Invest; 2004 Nov; 114(10):1409-11. PubMed ID: 15545990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy for human severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Le Deist F; de Saint Basile G; Cavazzana-Calvo M
    Immunity; 2001 Jul; 15(1):1-4. PubMed ID: 11485732
    [No Abstract]   [Full Text] [Related]  

  • 33. Severe combined immune deficiency in an adenosine deaminase-deficient patient.
    Ozdemir O
    Allergy Asthma Proc; 2006; 27(2):172-4. PubMed ID: 16724639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic therapy using bone marrow transplantation.
    Giles RE; Hanania EG; Fu S; Deisseroth A
    Cancer Treat Res; 1995; 76():271-80. PubMed ID: 7577339
    [No Abstract]   [Full Text] [Related]  

  • 35. A Journey in the Development of Gene Therapy for Inherited Disorders of the Bone Marrow.
    Kohn D; Wilson JM
    Hum Gene Ther Clin Dev; 2015 Dec; 26(4):203-7. PubMed ID: 26684443
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene therapy for severe combined immunodeficiency: are we there yet?
    Cavazzana-Calvo M; Fischer A
    J Clin Invest; 2007 Jun; 117(6):1456-65. PubMed ID: 17549248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Severe combined immunodeficiency].
    Okawa H
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):235-9. PubMed ID: 9833479
    [No Abstract]   [Full Text] [Related]  

  • 38. [It is no more about cancer, but it is already about gene therapy].
    Jeanteur P
    Bull Cancer; 2000 Jun; 87(6):445-6. PubMed ID: 10928794
    [No Abstract]   [Full Text] [Related]  

  • 39. [Omenn syndrome].
    Yachie A
    Ryoikibetsu Shokogun Shirizu; 2000; (32):23-6. PubMed ID: 11212702
    [No Abstract]   [Full Text] [Related]  

  • 40. ADA activity and DATP levels in erythrocytes after bone marrow transplantation.
    Fairbanks LD; Simmonds HA; Duley JA; Gaspar HB; Flood T; Steward CA
    Adv Exp Med Biol; 2000; 486():51-5. PubMed ID: 11783527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.